Many people see virtual presentations as less than in-person ones. But virtual is where visibility happens now. Here's how to ...

Alai is a pretty neat AI tool that really tries to make presentation creation less of a headache. What sets it apart, I think ...

The 2025-2026 IMAGINE Arts Incubator Program has selected six successful applicants from across Canada, including Kingston's ...

Centers for civic education at Iowa's universities have spent the past months developing programming and courses for students ...

The 2026 Bulloch Career–Workforce Summit served as a reminder of the role Career, Technical, and Agricultural Education plays ...

The Buncombe County Board of Commissioners met on January 20, 2026, where it approved participation in a program supporting sustainable commercial development financing, received an annual update from ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--#ETX101--Encoded Therapeutics Inc. (“Encoded”), a clinical-stage biotechnology company developing genetic medicines for severe neurological disorders, ...

Employees in the professional, operational support and skilled trades career streams are invited to apply for the STAR Program, a dynamic professional development program created to empower career ...

The Trump administration is soon expected to propose a plan that would cap loans for a number of advanced degrees—including master’s and doctoral degrees in nursing—and it’s gone viral on social media ...

GRAND RAPIDS, Mich. — Nestled amidst the medical marvel that is Grand Rapids' Medical Mile, Grand Valley State University's nursing program is known far and wide. Its towering structures and ...

NEW HAVEN, Conn., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today ...

Vepdegestrant is an investigational, orally bioavailable PROTAC estrogen receptor degrader. In the VERITAC-2 Phase 3 study, vepdegestrant demonstrated statistically significant and clinically ...